Finnrick - Ensuring a Safer and More Transparent Supply Chain
Limitless Life Nootropics

Limitless Life Nootropics
Retatrutide

Finnrick tested 4 samples of Retatrutide (GLP-1, GIP, and GCGR antagonist) from Limitless Life Nootropics between 13 Feb 2025 and 19 Feb 2025. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).

Finnrick Rating™
A
GREAT
Limitless Life Nootropics
Retatrutide
Tested 4 Samples
Last test 19 Feb 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Retatrutide tests from top-rated vendors:

All Retatrutide tests from Limitless Life Nootropics

Samples are tested in commercial labs

Tests Count

4

Scores

AVG8.4MIN6.4MAX10.0

Last

19 Feb 2025

First

13 Feb 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
19 Feb 2025View10.06mg6.250mg+4.2%99.95%1220White Label / Gold Crimp / Red CapLab BFinnrick
14 Feb 2025View6.46mg4.437mg-26.1%99.68%1220White Label / Gold Crimp / Red CapLab AFinnrick
13 Feb 2025View9.66mg5.635mg-6.1%98.48%1220White Label / Gold Crimp / Red CapLab CFinnrick
13 Feb 2025View7.86mg5.167mg-13.9%98.98%1220White Label / Gold Crimp / Red CapLab CFinnrick

Corrections

15 Apr 2025
Lab B test 19 Feb 2025: updated quantity following the identification of a clerical error, value was erroneously listed as 9.27mg. Lab issued an updated test certificate on 7 Apr 2025.